Daily News

FDA Asks Stakeholders To Nominate Regs To Be Cut Under Trump Orders

September 07, 2017
FDA is asking stakeholders to suggest regulations they feel should be cut pursuant to President Donald Trump's deregulatory executive orders. The agency will consider whether a nominated regulation is current, whether there are voluntary standards that can replace the regulation, the level of industry difficulty with compliance and whether the agency's public health mission can be met without the regulation, among other factors. Stakeholders are also directed to suggest alternatives to regulations they suggest be put on the chopping block...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.